AlphAIAlphAI — Financial news for AI agents
MarketBeatAPR 233 min read$CARE

Carter Bankshares (NASDAQ:CARE) Releases Quarterly Earnings Results, Misses Estimates By $0.09 EPS

Carter Bankshares (NASDAQ:CARE) reported its quarterly earnings, with an EPS of $0.40, missing the consensus estimate of $0.49 by $0.09. Despite the earnings miss, the company's revenue of $106.91 million significantly exceeded analysts' expectations of $42.47 million. Analysts have maintained a "Buy" rating for the stock, with institutional investors increasing their stakes, reflecting continued confidence in the company.

Original reporting
MarketBeat · MarketBeat
Published Apr 23, 2026, 4:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Apr 23, 2026, 5:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Carter Bankshares (NASDAQ:CARE) Releases Quarterly Earnings Results, Misses Estimates By $0.09 EPS — source image
Source · MarketBeat
Decision brief

The 30-second read

$CARENeutralMed
01

Why it matters

The earnings miss may temporarily dampen investor sentiment, but revenue beat and maintained buy ratings suggest resilience.

02

Market read

The news is highly relevant for investors holding or considering Carter Bankshares stock, especially in the short term.

03

What to watch

Potential macroeconomic influences or upcoming regulatory changes that could impact the banking sector.

Timing: Immediate, as earnings reports influence short-term trading decisions.

Background

Carter Bankshares is a regional bank with a focus on community banking services. Earnings reports are critical indicators of financial health and investor confidence.

Company-level read

Ticker impact

$CARENeutralMedium confidence
Context

The news pertains directly to Carter Bankshares, making it highly relevant for trading decisions.

Expected impact

Potential short-term decline followed by stabilization or slight rebound; long-term outlook remains cautiously optimistic.

Evidence & confidence

The earnings miss could negatively influence the stock temporarily, but strong revenue and positive analyst sentiment mitigate downside risks. Technical indicators and market sentiment are not provided, limiting precise prediction.

Market effects

Sector

The financial sector may experience slight negative sentiment due to earnings miss, but strong revenue figures could offset concerns.

Regional

Limited regional impact; specific to Carter Bankshares and its local markets.

Global

Negligible; the news is company-specific within the U.S. banking sector.

Counterpoint

What could challenge this read

The earnings miss could signal underlying issues not reflected in revenue, warranting caution before increasing exposure.

Key entities

  • Company
    Carter Bankshares

    A regional bank listed on NASDAQ, providing banking services.

  • Source
    MarketBeat

    Financial news and analysis provider.

Read at source← All news

Related articles

JUL 23
$CAREMed

Carter Bankshares, Inc. (CARE): Results of Operations and Financial Condition

Carter Bankshares, Inc. (CARE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 care-2q26_ex991xer.htm EX-99.1 Document Exhibit 99.1 FOR IMMEDIATE RELEASE – July 23, 2026 Carter Bankshares, Inc. Announces Second Quarter 2026 Financial Results Martinsville, VA, July 23, 2026 – Carter Bankshares, Inc. (the “Company”) (NASDAQ:CARE), the holding compan

SEC EDGAR 8-K6 min
SEP 29
$RCLMed

Is Royal Caribbean Cruises (RCL) Cheap On Analyst Upgrades And The Sandals Deal?

Royal Caribbean Cruises (RCL) has been upgraded by Bank of America and Deutsche Bank, citing a recent pullback and a Sandals Resorts partnership. The stock is down 13% in the past month and 24% in the past quarter, but has a 3-year total shareholder return of over 100%. Analysts estimate a fair value of $346.92, suggesting undervaluation. Revenue growth is expected from enhanced guest experiences and loyalty programs, but risks include consumer travel budgets and fuel costs.

simplywall.st2 min
SEP 29
$TMed

Can AT&T (T) Turn Higher ARPU Into Bigger Cash Flow?

BNP Paribas upgraded AT&T (T) to Outperform, raising its price target to $30. The firm cited a more rational U.S. wireless market and expected ARPU growth, which could boost revenue, EBITDA, and free cash flow. AT&T reported Q2 2026 revenues of $31.6B, EBITDA of $12.3B, and free cash flow of $4.7B, with plans to return $45B to shareholders by 2028. Concerns include high debt and legacy service declines.

insidermonkey.com2 min
SEP 28
$GILDMed

Can Lenacapavir Power Gilead Sciences (GILD)’s Next Growth Phase?

Gilead Sciences (GILD) expanded its royalty-free licensing for lenacapavir to include a once-yearly HIV PrEP formulation, covering 120 lower-income countries. The move aims to accelerate manufacturing and secure market dominance. Gilead's HIV sales grew 12% YoY to $5.7B in Q2 2026, but the company reported losses due to acquisition-related R&D charges.

insidermonkey.com3 min
SEP 28
$GSMed

Goldman Sachs CEO Transition: John Waldron Set to Succeed David

Goldman Sachs (GS) may see a leadership change, with John Waldron potentially replacing David Solomon as CEO. Solomon could become Executive Chairman. GS has a 2.03% dividend yield, a GF Score of 83, and is seen as 9.8% overvalued. Insider selling has been significant, with $1.09M in sales over three months. The firm has a market cap of $266.79B and operates in investment banking, asset management, and transaction banking.

gurufocus.com2 min